Page last updated: 2024-09-04

docetaxel anhydrous and Bronchial Neoplasms

docetaxel anhydrous has been researched along with Bronchial Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balázs, G; Kovalszky, I; Losonczy, G; Moldvay, J; Pápay, J; Puskás, R	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Bronchial Neoplasms

Article	Year
[Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission]. Magyar onkologia, 2014, Volume: 58, Issue:2 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Bronchial Neoplasms; Disease Progression; Docetaxel; ErbB Receptors; Exons; Female; Gefitinib; Gene Deletion; Genes, erbB-1; Humans; Molecular Targeted Therapy; Quinazolines; Remission Induction; Retreatment; Taxoids; Treatment Outcome	2014

Article

Year

[Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission].

Magyar onkologia, 2014, Volume: 58, Issue:2

Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Bronchial Neoplasms; Disease Progression; Docetaxel; ErbB Receptors; Exons; Female; Gefitinib; Gene Deletion; Genes, erbB-1; Humans; Molecular Targeted Therapy; Quinazolines; Remission Induction; Retreatment; Taxoids; Treatment Outcome

2014